BIST10014.396,54 -0.43%Moderna'nın Kanser Aşısı Coşkusu Kar Satışlarına Yenik Düştü: 18 Milyar Dolarlık ErimeUSD/TRY48.2416 0.20%Moderna'nın Kişiselleştirilmiş mRNA Kumarı: Onkolojide Devrim mi, Borsa Balonu mu?EUR/TRY56.0523 0.30%Norveç'in Temmuz Petrol Üretimindeki %10 Düşüş, Avrupa Enerji Piyasalarını SarsıyorBTC/USD$72,656.01 6.17%XRP’in 2024 Seçim Sonrası En İyi Haftası ve Bitcoin Kısa Sıkışması Piyasayı SalladıGRAM ALTIN6.951,61 0.15%İngiliz Bankalarının Yeni Maliye Bakanına Sert Uyarısı ve Piyasa YansımalarıBRENT$93.51 2.06%Faiz Yükselmesiyle Borsa Kabarcıklarının Patlaması Tehlikesi: Piyasalar Nasıl Yanıt Verecek?Yapay Zeka Çağında İnsan Sermayesinin Direnci: Finansal Piyasalara YansımalarıBIST10014.396,54 -0.43%Moderna'nın Kanser Aşısı Coşkusu Kar Satışlarına Yenik Düştü: 18 Milyar Dolarlık ErimeUSD/TRY48.2416 0.20%Moderna'nın Kişiselleştirilmiş mRNA Kumarı: Onkolojide Devrim mi, Borsa Balonu mu?EUR/TRY56.0523 0.30%Norveç'in Temmuz Petrol Üretimindeki %10 Düşüş, Avrupa Enerji Piyasalarını SarsıyorBTC/USD$72,656.01 6.17%XRP’in 2024 Seçim Sonrası En İyi Haftası ve Bitcoin Kısa Sıkışması Piyasayı SalladıGRAM ALTIN6.951,61 0.15%İngiliz Bankalarının Yeni Maliye Bakanına Sert Uyarısı ve Piyasa YansımalarıBRENT$93.51 2.06%Faiz Yükselmesiyle Borsa Kabarcıklarının Patlaması Tehlikesi: Piyasalar Nasıl Yanıt Verecek?Yapay Zeka Çağında İnsan Sermayesinin Direnci: Finansal Piyasalara Yansımaları
Global Markets

Bill Ackman's New Closed-End Fund Trades 20% Below IPO Price: Is the Berkshire-Style Bet Broken?

724FinanceDr. Yaman Ege
Key Highlights

Bill Ackman'un Pershing Square USA kapalı son fonu, açık arttırma fiyatından %20'lık bir indirimle piyasada işlem görürken, yatırımcılar Warren Buffet

Bill Ackman's New Closed-End Fund Trades 20% Below IPO Price: Is the Berkshire-Style Bet Broken?

Bill Ackman's Pershing Square USA closed-end fund is trading at a 20% discount to its IPO price, raising questions about whether the Berkshire-style investment model holds up in this structure. Unlike Berkshire Hathaway's operating company framework, the fund relies heavily on portfolio selection, creating a disconnect between its net asset value (NAV) and market price. While investors can purchase $1 worth of assets for $0.80, the structural nuances of closed-end funds highlight risks in transparency and long-term sustainability.

The Discount Dilemma in Closed-End Funds

  • Pershing Square USA (NYSE: PSUS) operates as a closed-end fund with a fixed share count, leading to a persistent NAV-price mismatch that diverges from Berkshire Hathaway's operational model.
  • The fund's structure allows direct exposure to Ackman's portfolio choices but lacks the flexibility of traditional mutual funds or operating companies.
  • A 20% discount reflects market skepticism toward Ackman's strategy, particularly amid rising volatility indicators like the VIX.
  • Unlike Berkshire's diversified business empire, the fund's performance hinges on asset selection rather than operational synergies.
  • Ege Kaan Note: The 20% discount in Pershing Square USA isn't just an opportunity—it's a red flag for structural opacity. Closed-end funds often trade at NAV deviations due to market sentiment, especially in volatile environments. Investors must weigh portfolio quality against the inherent risks of this format, particularly when gamma squeezes and macroeconomic pressures amplify uncertainty.

    Clash Between Buffett's Legacy and Ackman's Structure

  • Berkshire Hathaway continues under Greg Abel's leadership, maintaining Buffett's operational focus, while Ackman's fund prioritizes portfolio management.
  • Ackman's shift toward insurance via Howard Hughes Holdings (NYSE: HHH) mirrors Buffett's formula but remains in early stages of development.
  • Closed-end funds offer direct access to Ackman's strategy but lack the capital flexibility of mutual funds or operating companies.
  • Market scrutiny intensifies as investors question the fund's resilience against short-term volatility and structural inefficiencies.
  • Related News & Analysis

    View All →

    Latest Market News

    All News →
    Dr. Yaman Ege

    Financial Analyst: Dr. Yaman Ege

    Semiconductor and Tech Supply Chain Director. Industrial futurist analyzing TSMC capacities, ASML machines, and the US-China rare earth war's impact on tech stocks.

    Disclaimer: The investment information, comments, and recommendations contained herein are not within the scope of investment advisory. Investment advisory services are provided individually by authorized institutions, taking into account the risk and return preferences of individuals. The comments and recommendations contained herein are general in nature. These recommendations may not be suitable for your financial situation and your risk and return preferences. Therefore, making an investment decision based solely on the information contained herein may not produce results that meet your expectations.

    © 2026 724Finance - All Rights Reserved.Original Source: Finance.yahoo.com